| 1 |
34843701 | Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome. | 2022 Jan 15 |
2 |
| 2 |
34875285 | Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome. | 2022 Mar 1 |
1 |
| 3 |
34980259 | Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). | 2022 Jan 3 |
2 |
| 4 |
35212623 | Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome. | 2022 Feb 25 |
2 |
| 5 |
35256591 | mTORC1 induces plasma membrane depolarization and promotes preosteoblast senescence by regulating the sodium channel Scn1a. | 2022 Mar 8 |
2 |
| 6 |
35370551 | Functional Investigation of a Neuronal Microcircuit in the CA1 Area of the Hippocampus Reveals Synaptic Dysfunction in Dravet Syndrome Mice. | 2022 |
2 |
| 7 |
35435735 | Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates. | 2022 Jun |
4 |
| 8 |
33234612 | Impaired θ-γ Coupling Indicates Inhibitory Dysfunction and Seizure Risk in a Dravet Syndrome Mouse Model. | 2021 Jan 20 |
3 |
| 9 |
33411788 | Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy. | 2021 Jan |
2 |
| 10 |
33436636 | Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition. | 2021 Jan 12 |
1 |
| 11 |
33651714 | Neddylation stabilizes Nav1.1 to maintain interneuron excitability and prevent seizures in murine epilepsy models. | 2021 Apr 15 |
1 |
| 12 |
33658306 | Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS. | 2021 Mar-Apr |
1 |
| 13 |
33855971 | Epilepsy channelopathies go neddy: stabilizing NaV1.1 channels by neddylation. | 2021 Apr 15 |
2 |
| 14 |
34308420 | Combined Antiseizure Efficacy of Cannabidiol and Clonazepam in a Conditional Mouse Model of Dravet Syndrome. | 2021 |
2 |
| 15 |
34324871 | Clonazepam attenuates neurobehavioral abnormalities in offspring exposed to maternal immune activation by enhancing GABAergic neurotransmission. | 2021 Oct |
2 |
| 16 |
31607539 | dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice. | 2020 Jan 8 |
1 |
| 17 |
31830809 | Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome. | 2020 Mar |
2 |
| 18 |
31880072 | First FHM3 mouse model shows spontaneous cortical spreading depolarizations. | 2020 Jan |
1 |
| 19 |
32394465 | A 5-HT1D -receptor agonist protects Dravet syndrome mice from seizure and early death. | 2020 Nov |
2 |
| 20 |
32848094 | Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. | 2020 Aug 26 |
1 |
| 21 |
33584198 | Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments. | 2020 |
1 |
| 22 |
31578435 | Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation. | 2019 Oct 2 |
2 |
| 23 |
31758544 | Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice. | 2019 Dec |
1 |
| 24 |
28987817 | The sodium channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5/6+/- mice. | 2018 Jan 1 |
1 |
| 25 |
29875317 | NaV1.1 inhibition can reduce visceral hypersensitivity. | 2018 Jun 7 |
1 |
| 26 |
29956586 | Nonmuscle myosin II isoforms interact with sodium channel alpha subunits. | 2018 Jan-Dec |
1 |
| 27 |
30104343 | A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. | 2018 Sep 5 |
1 |
| 28 |
28490751 | Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome. | 2017 May 10 |
1 |
| 29 |
26819275 | Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy. | 2016 Apr |
2 |
| 30 |
22260870 | Dorsal root ganglia isolated from Nf1+/- mice exhibit increased levels of mRNA expression of voltage-dependent sodium channels. | 2012 Mar 29 |
1 |
| 31 |
22705271 | Dravet syndrome: the main issues. | 2012 Sep |
1 |
| 32 |
22787629 | Sodium Channel Mutations and Epilepsy | 2012 |
1 |
| 33 |
21463282 | Insights into pathophysiology and therapy from a mouse model of Dravet syndrome. | 2011 Apr |
1 |
| 34 |
20194124 | NaV1.1 channels and epilepsy. | 2010 Jun 1 |
1 |
| 35 |
17928448 | Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. | 2007 Oct 10 |
2 |
| 36 |
16921370 | Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. | 2006 Sep |
2 |
| 37 |
14715935 | Production of resurgent current in NaV1.6-null Purkinje neurons by slowing sodium channel inactivation with beta-pompilidotoxin. | 2004 Jan 7 |
1 |